Dioseve
Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden
$7MSeries A+
Role not disclosedDD
DG Daiwa Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
DG Daiwa Ventures is the investment organization named in Dioseve and Tellus Global financing coverage.
Recorded funding activity
Tellus combines satellite imagery, analysis tools and cloud computing for public and commercial users. Dioseve develops cell-based co-culture technology intended to improve egg maturation and reduce the burden of IVF. These company records retain distinct products and financing events.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $7M 1 disclosed · full round size, not this investor’s share